Lipopolysaccharide Receptors
"Lipopolysaccharide Receptors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Glycolipid-anchored membrane glycoproteins expressed on cells of the myelomonocyte lineage including MONOCYTES; MACROPHAGES; and some GRANULOCYTES. They function as receptors for the complex of lipopolysaccharide (LPS) and LPS-binding protein.
Descriptor ID |
D018950
|
MeSH Number(s) |
D12.776.395.550.448.100 D12.776.543.484.500.100 D12.776.543.550.418.100 D12.776.543.750.705.045 D23.050.301.264.900.045 D23.101.100.900.045
|
Concept/Terms |
Lipopolysaccharide Receptors- Lipopolysaccharide Receptors
- Lipoglycan Receptor
- Receptor, Lipoglycan
- Receptors, Lipopolysaccharide
- CD14 Antigens
- Antigens, CD14
- LPS Receptor
- Receptor, LPS
- CD14 Monocyte Differentiation Antigen
- CD14 Antigen
|
Below are MeSH descriptors whose meaning is more general than "Lipopolysaccharide Receptors".
- Chemicals and Drugs [D]
- Amino Acids, Peptides, and Proteins [D12]
- Proteins [D12.776]
- Glycoproteins [D12.776.395]
- Membrane Glycoproteins [D12.776.395.550]
- GPI-Linked Proteins [D12.776.395.550.448]
- Lipopolysaccharide Receptors [D12.776.395.550.448.100]
- Membrane Proteins [D12.776.543]
- Lipid-Linked Proteins [D12.776.543.484]
- GPI-Linked Proteins [D12.776.543.484.500]
- Lipopolysaccharide Receptors [D12.776.543.484.500.100]
- Membrane Glycoproteins [D12.776.543.550]
- GPI-Linked Proteins [D12.776.543.550.418]
- Lipopolysaccharide Receptors [D12.776.543.550.418.100]
- Receptors, Cell Surface [D12.776.543.750]
- Receptors, Immunologic [D12.776.543.750.705]
- Lipopolysaccharide Receptors [D12.776.543.750.705.045]
- Biological Factors [D23]
- Antigens [D23.050]
- Antigens, Surface [D23.050.301]
- Antigens, Differentiation [D23.050.301.264]
- Antigens, Differentiation, Myelomonocytic [D23.050.301.264.900]
- Lipopolysaccharide Receptors [D23.050.301.264.900.045]
- Biomarkers [D23.101]
- Antigens, Differentiation [D23.101.100]
- Antigens, Differentiation, Myelomonocytic [D23.101.100.900]
- Lipopolysaccharide Receptors [D23.101.100.900.045]
Below are MeSH descriptors whose meaning is more specific than "Lipopolysaccharide Receptors".
This graph shows the total number of publications written about "Lipopolysaccharide Receptors" by people in this website by year, and whether "Lipopolysaccharide Receptors" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2000 | 1 | 0 | 1 |
2001 | 0 | 1 | 1 |
2002 | 0 | 1 | 1 |
2003 | 0 | 1 | 1 |
2004 | 1 | 1 | 2 |
2006 | 0 | 1 | 1 |
2009 | 0 | 1 | 1 |
2010 | 1 | 0 | 1 |
2011 | 0 | 1 | 1 |
2012 | 2 | 0 | 2 |
2015 | 1 | 1 | 2 |
2017 | 0 | 1 | 1 |
2018 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Lipopolysaccharide Receptors" by people in Profiles.
-
Plasma Biomarkers of Inflammation and Angiogenesis Predict Cerebral Cavernous Malformation Symptomatic Hemorrhage or Lesional Growth. Circ Res. 2018 06 08; 122(12):1716-1721.
-
Endothelial TLR4 and the microbiome drive cerebral cavernous malformations. Nature. 2017 05 18; 545(7654):305-310.
-
The Association of Human Cytomegalovirus with Biomarkers of Inflammation and Immune Activation in HIV-1-Infected Women. AIDS Res Hum Retroviruses. 2016 Feb; 32(2):134-43.
-
Mammalian Lipopolysaccharide Receptors Incorporated into the Retroviral Envelope Augment Virus Transmission. Cell Host Microbe. 2015 Oct 14; 18(4):456-62.
-
Human lipopolysaccharide-binding protein (LBP) and CD14 independently deliver triacylated lipoproteins to Toll-like receptor 1 (TLR1) and TLR2 and enhance formation of the ternary signaling complex. J Biol Chem. 2013 Apr 05; 288(14):9729-9741.
-
GM-CSF increases LPS-induced production of proinflammatory mediators via upregulation of TLR4 and CD14 in murine microglia. J Neuroinflammation. 2012 Dec 13; 9:268.
-
CD14(+)S100A9(+) myeloid-derived suppressor cells portend decreased survival in patients with advanced lung cancer. Am J Respir Crit Care Med. 2012 Nov 15; 186(10):940-1.
-
The effect of mesenchymal stromal cell-hyaluronic acid hydrogel constructs on immunophenotype of macrophages. Tissue Eng Part A. 2011 Oct; 17(19-20):2463-71.
-
Renal CD14 expression correlates with the progression of cystic kidney disease. Kidney Int. 2010 Sep; 78(6):550-60.
-
Porcine EPCs downregulate stem cell markers and upregulate endothelial maturation markers during in vitro cultivation. J Tissue Eng Regen Med. 2009 Oct; 3(7):512-20.